Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Castellan Group

Castellan Group lowered its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 87.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,000 shares of the biopharmaceutical company’s stock after selling 26,725 shares during the quarter. Castellan Group’s holdings in Bristol-Myers Squibb were […]

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Christophers Boerner ,Pomalyst Imnovid ,Bristol Myers Squibb ,Barclays ,Westshore Wealth ,Cherry Creek Investment Advisors Inc ,Castellan Group ,Cantor Fitzgerald ,Providence Wealth Advisors ,Abbrea Capital ,Bristol Myers Squibb Company ,Stolper Co ,Securities Exchange Commission ,Free Report ,Wealth Advisors ,Cherry Creek Investment Advisors ,Creek Investment Advisors ,Exchange Commission ,Myers Squibb ,Get Free Report ,Myers Squibb Company ,Visit Holdingschannel ,Bristol Myers Squibb Daily ,Nyse Bmy ,Bmy ,Medical ,11012210 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,